Search Results

There are 445832 results for: content related to: Prevalence and clinical features of LRRK2 mutations in patients with Parkinson’s disease in southern Spain

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 60
  4. 61 - 80
  5. Next >
  1. You have free access to this content
    LRRK2 in Parkinson’s disease: in vivo models and approaches for understanding pathogenic roles

    FEBS Journal

    Volume 276, Issue 22, November 2009, Pages: 6445–6454, Zhenyu Yue

    Article first published online : 5 OCT 2009, DOI: 10.1111/j.1742-4658.2009.07343.x

  2. Striatal leucine-rich repeat kinase 2 mRNA is increased in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned common marmosets (Callithrix jacchus) with l-3, 4-dihydroxyphenylalanine methyl ester-induced dyskinesia

    European Journal of Neuroscience

    Volume 26, Issue 1, July 2007, Pages: 171–177, M. J. Hurley, P. H. Patel, M. J. Jackson, L. A. Smith, S. Rose and P. Jenner

    Article first published online : 3 JUL 2007, DOI: 10.1111/j.1460-9568.2007.05638.x

  3. LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease

    Movement Disorders

    Volume 25, Issue 15, 15 November 2010, Pages: 2536–2541, Rachel Saunders-Pullman, Matthew J. Barrett, Kaili M. Stanley, Marta San Luciano, Vicki Shanker, Lawrence Severt, Ann Hunt, Deborah Raymond, Laurie J. Ozelius and Susan B. Bressman

    Article first published online : 3 SEP 2010, DOI: 10.1002/mds.23314

  4. Deep sequencing of the LRRK2 gene in 14,002 individuals reveals evidence of purifying selection and independent origin of the p.Arg1628Pro mutation in Europe

    Human Mutation

    Volume 33, Issue 7, July 2012, Pages: 1087–1098, Justin P. Rubio, Simon Topp, Liling Warren, Pamela L. St. Jean, Daniel Wegmann, Darren Kessner, John Novembre, Judong Shen, Dana Fraser, Jennifer Aponte, Keith Nangle, Lon R. Cardon, Margaret G. Ehm, Stephanie L. Chissoe, John C. Whittaker, Matthew R. Nelson and Vincent E. Mooser

    Article first published online : 4 APR 2012, DOI: 10.1002/humu.22075

  5. Screening for SNCA and LRRK2 mutations in Greek sporadic and autosomal dominant Parkinson's disease: identification of two novel LRRK2 variants

    European Journal of Neurology

    Volume 14, Issue 1, January 2007, Pages: 7–11, G. Xiromerisiou, G. M. Hadjigeorgiou, V. Gourbali, J. Johnson, I. Papakonstantinou, A. Papadimitriou and A. B. Singleton

    Article first published online : 21 SEP 2006, DOI: 10.1111/j.1468-1331.2006.01551.x

  6. You have free access to this content
    Leucine-rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease

    Journal of Neuroscience Research

    Volume 87, Issue 6, 1 May 2009, Pages: 1283–1295, Payal N. Gandhi, Shu G. Chen and Amy L. Wilson-Delfosse

    Article first published online : 21 NOV 2008, DOI: 10.1002/jnr.21949

  7. Screening for LRRK2 mutations in patients with Parkinson’s disease in Russia: identification of a novel LRRK2 variant

    European Journal of Neurology

    Volume 15, Issue 7, July 2008, Pages: 692–696, S. N. Pchelina, A. F. Yakimovskii, A. K. Emelyanov, O. N. Ivanova, A. L. Schwarzman and A. B. Singleton

    Article first published online : 24 APR 2008, DOI: 10.1111/j.1468-1331.2008.02149.x

  8. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Article first published online : 19 JUN 2012, DOI: 10.1002/mds.25051

  9. Parkinson's disease: the genetics of a heterogeneous disorder

    European Journal of Neurology

    Volume 13, Issue 6, June 2006, Pages: 616–627, D. Gosal, O. A. Ross and M. Toft

    Article first published online : 6 JUN 2006, DOI: 10.1111/j.1468-1331.2006.01336.x

  10. You have full text access to this OnlineOpen article
    Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment

    Journal of Neurochemistry

    Volume 111, Issue 3, November 2009, Pages: 703–715, Christian L. Klein, Giorgio Rovelli, Wolfdieter Springer, Christoph Schall, Thomas Gasser and Philipp J. Kahle

    Article first published online : 27 AUG 2009, DOI: 10.1111/j.1471-4159.2009.06358.x

  11. Leucine-rich repeat kinase 2 disturbs mitochondrial dynamics via Dynamin-like protein

    Journal of Neurochemistry

    Volume 122, Issue 3, August 2012, Pages: 650–658, Jingwen Niu, Mei Yu, Chunyan Wang and Zhiheng Xu

    Article first published online : 22 JUN 2012, DOI: 10.1111/j.1471-4159.2012.07809.x

  12. Olfactory deficits and cardiac 123I-MIBG in Parkinson's disease related to the LRRK2 R1441G and G2019S mutations

    Movement Disorders

    Volume 26, Issue 11, September 2011, Pages: 2026–2031, Javier Ruiz-Martínez, Ana Gorostidi, Estibaliz Goyenechea, Ainhoa Alzualde, Juan José Poza, Francisco Rodríguez, Alberto Bergareche, Fermín Moreno, Adolfo López de Munain and José F. Martí Massó

    Article first published online : 24 MAY 2011, DOI: 10.1002/mds.23773

  13. LRRK2 is expressed in areas affected by Parkinson's disease in the adult mouse brain

    European Journal of Neuroscience

    Volume 23, Issue 3, February 2006, Pages: 659–666, Javier Simón-Sánchez, Vicente Herranz-Pérez, Francisco Olucha-Bordonau and Jordi Pérez-Tur

    Article first published online : 16 FEB 2006, DOI: 10.1111/j.1460-9568.2006.04616.x

  14. LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation

    Movement Disorders

    Volume 27, Issue 1, January 2012, Pages: 146–150, Oswaldo Lorenzo-Betancor, Lluís Samaranch, Mario Ezquerra, Eduardo Tolosa, Elena Lorenzo, Jaione Irigoyen, Carles Gaig, María A. Pastor, Alexandra I. Soto-Ortolaza, Owen A. Ross, María C. Rodríguez-Oroz, Francesc Valldeoriola, María J. Martí, María R. Luquin, Jordi Perez-Tur, Juan A. Burguera, José A. Obeso and Pau Pastor

    Article first published online : 28 OCT 2011, DOI: 10.1002/mds.23968

  15. Genetic LRRK2 models of Parkinson's disease: Dissecting the pathogenic pathway and exploring clinical applications

    Movement Disorders

    Volume 26, Issue 8, July 2011, Pages: 1386–1397, Zhenyu Yue and M. Lenard Lachenmayer

    Article first published online : 29 APR 2011, DOI: 10.1002/mds.23737

  16. You have free access to this content
    LRRK2 gene variation and its contribution to Parkinson disease

    Human Mutation

    Volume 30, Issue 8, August 2009, Pages: 1153–1160, Coro Paisán-Ruiz

    Article first published online : 21 APR 2009, DOI: 10.1002/humu.21038

  17. Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease

    Movement Disorders

    Volume 27, Issue 8, July 2012, Pages: 1004–1011, David A. Elliott, Woojin S. Kim, Sarsha Gorissen, Glenda M. Halliday and John B.J. Kwok

    Article first published online : 23 APR 2012, DOI: 10.1002/mds.25005

  18. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal

    Movement Disorders

    Volume 22, Issue 8, 15 June 2007, Pages: 1194–1201, Joaquim J. Ferreira, Leonor Correia Guedes, Mário Miguel Rosa, Miguel Coelho, Marina van Doeselaar, Dorothea Schweiger, Alessio Di Fonzo, Ben A. Oostra, Cristina Sampaio and Vincenzo Bonifati

    Article first published online : 27 APR 2007, DOI: 10.1002/mds.21525

  19. LRRK2 and Parkinson’s disease in Norway

    Acta Neurologica Scandinavica

    Volume 115, Issue s187, May 2007, Pages: 72–75, M. Toft, K. Haugarvoll, O. A. Ross, M. J. Farrer and J. O. Aasly

    Article first published online : 29 MAR 2007, DOI: 10.1111/j.1600-0404.2007.00852.x

  20. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia

    European Journal of Neurology

    Volume 14, Issue 4, April 2007, Pages: 413–417, S. N. Illarioshkin, M. I. Shadrina, P. A. Slominsky, E. V. Bespalova, T. B. Zagorovskaya, G. Kh. Bagyeva, E. D. Markova, S. A. Limborska and I. A. Ivanova-Smolenskaya

    Article first published online : 23 MAR 2007, DOI: 10.1111/j.1468-1331.2007.01685.x

VIEW

  1. 1 - 20
  2. 21 - 40
  3. 41 - 60
  4. 61 - 80
  5. Next >